SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Richards Group Reports Q3 Revenue Up 2%, Gross Margins Up 7%

Revenue rose 2% primarily from acquisitions, while gross margins increased 7%. Healthcare benefited from DermapenWorld and PharmaSystems; packaging demand remained soft.

RIC

Richards Group reported Q3 2026 results: revenue up 2% primarily from acquisitions and gross margins up 7%. Healthcare benefited from DermapenWorld and PharmaSystems; Packaging demand remained soft.Material DetailsContext by AI AnalystThis update extends a trend of acquisition-led growth amid mixed…

Related stories